The inhibition of the RAAS, using ACE inhibitors (ACEi) or angiotensin receptor blockers, has been shown to mitigate oxygen-induced retinopathy (Moravski et al. 2000; Shi et al. 2023), suggesting that RAAS inhibition could be a promising therapeutic approach for ROP. This evidence concerns the gene ACE and retinopathy of prematurity.